Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI Stock
Recordati Industria Chimica e Farmaceutica S.p.A. Price Chart
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI Financial and Trading Overview
Contents
- Recordati Industria Chimica e Farmaceutica S.p.A. Price Chart
- Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Recordati Industria Chimica e Farmaceutica S.p.A.
- Q&A For Recordati Industria Chimica e Farmaceutica S.p.A. Stock
Recordati Industria Chimica e Farmaceutica S.p.A. stock price | 49.42 EUR |
Previous Close | 44.93 EUR |
Open | 45.23 EUR |
Bid | 45.36 EUR x 0 |
Ask | 45.38 EUR x 0 |
Day's Range | 45.02 - 45.5 EUR |
52 Week Range | 34.52 - 46.16 EUR |
Volume | 46.47K EUR |
Avg. Volume | 259.09K EUR |
Market Cap | 9.43B EUR |
Beta (5Y Monthly) | 0.265134 |
PE Ratio (TTM) | 28.72152 |
EPS (TTM) | 1.86 EUR |
Forward Dividend & Yield | 1.2 (2.64%) |
Ex-Dividend Date | May 22, 2023 |
1y Target Est | 45.7 EUR |
REC.MI Valuation Measures
Enterprise Value | 10.61B EUR |
Trailing P/E | 28.72152 |
Forward P/E | 19.31064 |
PEG Ratio (5 yr expected) | 1.89 |
Price/Sales (ttm) | 4.7480917 |
Price/Book (mrq) | 5.6351666 |
Enterprise Value/Revenue | 5.342 |
Enterprise Value/EBITDA | 15.095 |
Trading Information
Recordati Industria Chimica e Farmaceutica S.p.A. Stock Price History
Beta (5Y Monthly) | 0.265134 |
52-Week Change | 15.14% |
S&P500 52-Week Change | 20.43% |
52 Week High | 46.16 EUR |
52 Week Low | 34.52 EUR |
50-Day Moving Average | 42.31 EUR |
200-Day Moving Average | 40.05 EUR |
REC.MI Share Statistics
Avg. Volume (3 month) | 259.09K EUR |
Avg. Daily Volume (10-Days) | 290.41K EUR |
Shares Outstanding | 205.36M |
Float | 99.03M |
Short Ratio | N/A |
% Held by Insiders | 51.82% |
% Held by Institutions | 26.54% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.15 |
Trailing Annual Dividend Yield | 2.55% |
5 Year Average Dividend Yield | 247.00% |
Payout Ratio | 0.6892 |
Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 17.10% |
Operating Margin (ttm) | 29.28% |
Gross Margin | 71.53% |
EBITDA Margin | 35.39% |
Management Effectiveness
Return on Assets (ttm) | 9.53% |
Return on Equity (ttm) | 21.87% |
Income Statement
Revenue (ttm) | 1.99B EUR |
Revenue Per Share (ttm) | 9.66 EUR |
Quarterly Revenue Growth (yoy) | 31.50% |
Gross Profit (ttm) | 1.34B EUR |
EBITDA | 702.64M EUR |
Net Income Avi to Common (ttm) | 339.57M EUR |
Diluted EPS (ttm) | 1.58 |
Quarterly Earnings Growth (yoy) | 28.19% |
Balance Sheet
Total Cash (mrq) | 231.29M EUR |
Total Cash Per Share (mrq) | 1.13 EUR |
Total Debt (mrq) | 1.6B EUR |
Total Debt/Equity (mrq) | 96.49 EUR |
Current Ratio (mrq) | 1.352 |
Book Value Per Share (mrq) | 8.053 |
Cash Flow Statement
Operating Cash Flow (ttm) | 456.18M EUR |
Levered Free Cash Flow (ttm) | 226.78M EUR |
Profile of Recordati Industria Chimica e Farmaceutica S.p.A.
Country | Italy |
State | MI |
City | Milan |
Address | Via Matteo Civitali,1 |
ZIP | 20148 |
Phone | 39 02 487871 |
Website | https://www.recordati.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 4369 |
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
Q&A For Recordati Industria Chimica e Farmaceutica S.p.A. Stock
What is a current REC.MI stock price?
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI stock price today per share is 49.42 EUR.
How to purchase Recordati Industria Chimica e Farmaceutica S.p.A. stock?
You can buy REC.MI shares on the Milan exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Recordati Industria Chimica e Farmaceutica S.p.A.?
The stock symbol or ticker of Recordati Industria Chimica e Farmaceutica S.p.A. is REC.MI.
Which industry does the Recordati Industria Chimica e Farmaceutica S.p.A. company belong to?
The Recordati Industria Chimica e Farmaceutica S.p.A. industry is Drug Manufacturers-General.
How many shares does Recordati Industria Chimica e Farmaceutica S.p.A. have in circulation?
The max supply of Recordati Industria Chimica e Farmaceutica S.p.A. shares is 206.37M.
What is Recordati Industria Chimica e Farmaceutica S.p.A. Price to Earnings Ratio (PE Ratio)?
Recordati Industria Chimica e Farmaceutica S.p.A. PE Ratio is 26.56989100 now.
What was Recordati Industria Chimica e Farmaceutica S.p.A. earnings per share over the trailing 12 months (TTM)?
Recordati Industria Chimica e Farmaceutica S.p.A. EPS is 1.86 EUR over the trailing 12 months.
Which sector does the Recordati Industria Chimica e Farmaceutica S.p.A. company belong to?
The Recordati Industria Chimica e Farmaceutica S.p.A. sector is Healthcare.
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
Nasdaq CRD Global Sustainabilit NQCRD | 1735.62 USD — |
0
|
— — | 1715.94 USD — | 1757.95 USD — | — - | — — |
Nasdaq Developed Select Leaders NQDMSLC | 1260.81 USD — |
0
|
— — | 1243.71 USD — | 1264.94 USD — | — - | — — |
Next 150 Index N150 | 3360.4 EUR 3673.37 USD |
<0.01
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}